Determination of coagulation inhibitor levels and resistance to activated protein c in patients undergoing gastric surgery for benign and malignant disorders

Pathophysiology of Haemostasis and Thrombosis

Volumn 27, Issue 4, 1997, Pages 157-162

  Andersen, B S ^a   Rahr, H B ^a   Sorensen J V ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Activated protein C; Blood coagulation; Gastric surgery; Neoplasms; Resistance to

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; PROTEIN C; PROTEIN S; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGED; ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN DETERMINATION; STOMACH CANCER; STOMACH SURGERY;

AGED; AGED, 80 AND OVER; ANTITHROMBINS; BLOOD COAGULATION FACTOR INHIBITORS; CIRCADIAN RHYTHM; DRUG RESISTANCE; FEMALE; GASTRECTOMY; HEPARIN COFACTOR II; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; PROTEIN C; PROTEIN S; STOMACH DISEASES; STOMACH NEOPLASMS; TIME FACTORS;

EID: 0031466029     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217448     Document Type: Article

References (16)

1. Svensson PJ, Uahlbäck B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330:517-522.
2. Koster T, Rosendahl FR, de Ronde H, Briet E, Vandcnbroucke JP, Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993:342: 1503-1506.
3. Lindahl AK, Sandset PM, Abild-gaard U, Anderson TR, Harbitz TB: High plasma levels of intrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer. Acta Chir Scand 1989,55: 389-393.
4. Rahr HB, Sorensen JV: Venous thromboembolism and cancer. Blood Coagul Fibrinolysis 1992;3: 451-460.
5. Rahr HB. Sorensen JV, Larsen JF, Jensen FS, Bredahl C, Nicuwen-huizcn W: Haemostatic activation before and after surgery in patients with and without gastric malignancy. Thromb Haemost 1994;71:713-718.
6. Ostergaard PB, Beck T, Orsted H, Svendsen A, Nordfang O, Sandset PM, Hansen JB: An enzyme linked immunoabsorption assay for tissue factor pathway inhibitor. Thromb Res, in press.
7. Prcda L, Tripodi A, Alsecchi C, Lombardi A, Finotti E, Mannucci PM: A prothrombin time-based functional assay of protein S. Thromb Res 1990;60:19-32.
8. Sandsct PM, Hogcvold HE, Lyberg T, Anderson TR, Abildgaard U: Extrinsic pathway inhibitor in elective surgery. A comparison with other coagulation inhibitors. Thromb Hacmost 1989;62:856-860.
9. Andersson TR, Berner NS, Larsen MC, Odegaard OR, Abildgaard U: Plasma heparin cofactor II, protein C and antithrombin in elective surgery. Acta Chir Scand 1987; 153: 291-296.
10. Lindahl AK, Odegaard OR, Sandset PM, Thorstein BH: Coagulation inhibition and activation in pancreatic cancer. Cancer 1992,70:2067-2071.
11. Lindahl AK, Boffa M-C, Abildgaard U: Increased plasma thrombomodulin in cancer patients. Thromb Hacmost 1993;69:112-114.
12. Otterson GA, Monahan BP, Harold N, Steinberg SM, Frame JN, Kaye FJ: Clinical significance of the FV:506 mutation in unselected oncology patients. Am J Med 1996; 101:406-412.
13. Green D, Maliekel K, Sushko E, Akhtar R: Activated protein C resistance in cancer patients. Thromb Haemost 1997;316(suppl):p 316.
14. De Lucia D, Rcnis V, Del Giudice V. Di Mauro C, Donati MB, Iaco-viello L: Evidence for an acquired defect of APC-rcsistance in patients with advanced gastrointestinal cancer. Thromb Haemost 1997;316: (suppl):p 316.
15. Kwaan HC, Samama MM, Lc-compte T: Pathogenesis in Thrombosis; in Kwaan HC, Samama MM (eds): Clinical Thrombosis. Boca Raton, CRC Press, 1989, pp 33-49.
16. Hoye RC, Poulsen DF, Kctchan AS: Total circulating albumin deficits occurring with extensive surgical procedures. Surg Gynecol Obstet 1970;131:1943-1952.